How does anticoagulant therapy affect thrombolysis outcomes in superior vena cava syndrome, and what are the recommended protocols for effective management?
Gaurav ChauhanContributor
How does anticoagulant therapy affect thrombolysis in superior vena cava syndrome?
Share
Anticoagulant therapy can improve thrombolysis outcomes in SVCS by preventing new clot formation. Protocols often combine thrombolytics with anticoagulants like heparin.